Carbapenem-resistant Klebsiella pneumoniae is associated with high morbidity and mortality, and capsule serotypes make treatment difficult. The aim of this study is to investigate the relationship between colistin resistance and capsule types in carbapenem-resistant K. pneumoniae isolates. In 2018- 2020, we conducted our study with 115 carbapenem-resistant K. pneumoniae strains diagnosed by matrix-mediated laser desorption ionization time-of-flight mass spectrometry method (MALDI-TOF MS; Bruker Daltonics, Germany). Colistin sensitivities were determined by using DxM MicroScan WalkAway System (Beckman Coulter, ABD) automated system and were then verified by liquid microdilution (MIC). Capsule serotypes were investigated by conventional polymerase chain reaction (PCR) method. Among the carbapenem resistant K. pneumoniae isolates, 42% (48) were resistant to colistin and 58% (67) were susceptible to colistin. In the K. pneumoniae isolates with colistin resistance 33% (16) K5, 13% (6) K2, 8% (4) K20 4% (2) K1 and 2% (1) K54 and K57 capsule serotypes were found, while in the K. pneumoniae isolates with colistin susceptible 12% (8) K5, 4% (3) K2, 3% (2) K20, 1.5% (1) K1 and K54 capsule serotypes were found. Serotype K5 was very frequent in isolates collected from patients with urinary tract diseases. The resistance profile data obtained from the present study can serve as an information base to understand the infection pattern prevailing in the hospital.
Keywords: Carbapenem Resistant K. pneumoniae; colistin resistance; capsule serotypes.